ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures.

ClinicalTrials.gov ID: NCT01747915

Public ClinicalTrials.gov record NCT01747915. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 6:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTER TRIAL OF PREGABALIN AS ADJUNCTIVE THERAPY IN PEDIATRIC AND ADULT SUBJECTS WITH PRIMARY GENERALIZED TONIC-CLONIC SEIZURES - PROTOCOL A0081105

Study identification

NCT ID
NCT01747915
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Industry
Enrollment
219 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Pregabalin Dose Level 1 Drug
  • Pregabalin Dose Level 2 Drug

Drug

Eligibility (public fields only)

Age range
5 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2, 2013
Primary completion
Feb 19, 2019
Completion
Feb 19, 2019
Last update posted
Jan 19, 2021

2013 – 2019

United States locations

U.S. sites
12
U.S. states
6
U.S. cities
9
Facility City State ZIP Site status
Axcess Medical Research Loxahatchee Groves Florida 33470
Pediatric Epilepsy Center of Central Florida Orlando Florida 32819
Pediatric Neurology, PA Orlando Florida 32819
Medsol Clinical Research Center Port Charlotte Florida 33952
Hawaii Pacific Neuroscience Honolulu Hawaii 96817
Alexian Brothers Center for Psychiatric Research Hoffman Estates Illinois 60169
Chinmay K. Patel, D.O. Hoffman Estates Illinois 60169
St. Alexius Medical Center Hoffman Estates Illinois 60169
Ohio Clinical Research Partners, LLC Canton Ohio 44718
Road Runner Research, Ltd San Antonio Texas 78249
Scott & White Memorial Hospital and Clinic Temple Texas 76508
Rainier Clinical Research Center, Inc. Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 115 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01747915, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 19, 2021 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01747915 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →